Background: Aberrant expression of small noncoding RNAs called microRNAs (miRNAs) is a common feature of several human diseases. The objective of the study was to identify miRNA modulation in patients with complex regional pain syndrome (CRPS) a chronic pain condition resulting from dysfunction in the central and/or peripheral nervous systems. Due to a multitude of inciting pathologies, symptoms and treatment conditions, the CRPS patient population is very heterogeneous. Our goal was to identify differentially expressed miRNAs in blood and explore their utility in patient stratification.Methods: We profiled miRNAs in whole blood from 41 patients with CRPS and 20 controls using TaqMan low density array cards. Since neurogenic inflammation is known to play a significant role in CRPS we measured inflammatory markers including chemokines, cytokines, and their soluble receptors in blood from the same individuals. Correlation analyses were performed for miRNAs, inflammatory markers and other parameters including disease symptoms, medication, and comorbid conditions.Results: Three different groups emerged from miRNA profiling. One group was comprised of 60% of CRPS patients and contained no control subjects. miRNA profiles from the remaining patients were interspersed among control samples in the other two groups. We identified differential expression of 18 miRNAs in CRPS patients. Analysis of inflammatory markers showed that vascular endothelial growth factor (VEGF), interleukin1 receptor antagonist (IL1Ra) and monocyte chemotactic protein-1 (MCP1) were significantly elevated in CRPS patients. VEGF and IL1Ra showed significant correlation with the patients reported pain levels. Analysis of the patients who were clustered according to their miRNA profile revealed correlations that were not significant in the total patient population. Correlation analysis of miRNAs detected in blood with additional parameters identified miRNAs associated with comorbidities such as headache, thyroid disorder and use of narcotics and antiepileptic drugs.Conclusions: miRNA profiles can be useful in patient stratification and have utility as potential biomarkers for pain. Differentially expressed miRNAs can provide molecular insights into gene regulation and could lead to new therapeutic intervention strategies for CRPS. © 2011 Orlova et al; licensee BioMed Central Ltd.
I.A., O., G.M., A., R.A., Q., A., S., A., G., J.E., B., … S.K., A. (2011). MicroRNA modulation in complex regional pain syndrome. Journal of Translational Medicine, 9(1). https://doi.org/10.1186/1479-5876-9-195 LK - http://rug.on.worldcat.org/atoztitles/link/?sid=EMBASE&issn=14795876&id=doi:10.1186%2F1479-5876-9-195&atitle=MicroRNA+modulation+in+complex+regional+pain+syndrome&stitle=J.+Transl.+Med.&title=Journal+of+Translational+Medicine&volume=9&issue=1&spage=&epage=&aulast=Orlova&aufirst=Irina+A.&auinit=I.A.&aufull=Orlova+I.A.&coden=&isbn=&pages=-&date=2011&auinit1=I&auinitm=A.